scholarly journals Role of Intestinal Microbiota in the Bioavailability and Physiological Functions of Dietary Polyphenols

Molecules ◽  
2019 ◽  
Vol 24 (2) ◽  
pp. 370 ◽  
Author(s):  
Kyuichi Kawabata ◽  
Yasukiyo Yoshioka ◽  
Junji Terao
Keyword(s):  
Intestinal Microbiota ◽  
Physiological Function ◽  
Plant Secondary Metabolites ◽  
Fission Products ◽  
Intestinal Bacteria ◽  
Short Chain Fatty Acids ◽  
The Body ◽  
Physiological Functions ◽  
Dietary Polyphenols

Polyphenols are categorized as plant secondary metabolites, and they have attracted much attention in relation to human health and the prevention of chronic diseases. In recent years, a considerable number of studies have been published concerning their physiological function in the digestive tract, such as their prebiotic properties and their modification of intestinal microbiota. It has also been suggested that several hydrolyzed and/or fission products, derived from the catabolism of polyphenols by intestinal bacteria, exert their physiological functions in target sites after transportation into the body. Thus, this review article focuses on the role of intestinal microbiota in the bioavailability and physiological function of dietary polyphenols. Monomeric polyphenols, such as flavonoids and oligomeric polyphenols, such as proanthocyanidins, are usually catabolized to chain fission products by intestinal bacteria in the colon. Gallic acid and ellagic acid derived from the hydrolysis of gallotannin, and ellagitannin are also subjected to intestinal catabolism. These catabolites may play a large role in the physiological functions of dietary polyphenols. They may also affect the microbiome, resulting in health promotion by the activation of short chain fatty acids (SCFA) excretion and intestinal immune function. The intestinal microbiota is a key factor in mediating the physiological functions of dietary polyphenols.

scholarly journals Gut microbiota and metabolic syndrome

2020 ◽  
Vol 183 (11) ◽  
pp. 11-19
Author(s):  
V. B. Grinevich ◽  
V. G. Radchenko
Keyword(s):  
Metabolic Syndrome ◽  
Intestinal Microbiota ◽  
Metabolic Disorders ◽  
Bacterial Genome ◽  
Short Chain Fatty Acids ◽  
The Body ◽  
Enzymatic Reactions ◽  
Bacterial Films

Metabolic syndrome is associated with current diseases, such as obesity, diabetes, hypertension, which are accompanied by changes in the intestinal microbiota and the functioning of the immune and neuro-humoral systems of the body. Without detracting from the role of heredity and environmental factors, the intestinal microbiota makes a significant contribution to the development of metabolic disorders and obesity by modulating cascading enzymatic reactions of the macroorganism, interacting with receptors directly and/or using its own metabolites and signaling molecules.The purpose of study was to analyze the literature data obtained in the study of the role of the intestinal microbiota in the development of metabolic syndrome (MS).Results: A review of current literature on the role of intestinal microbiota in the development of metabolic syndrome is presented. The features of the mucosal microflora of the colon, the role of bacterial films, epithelial lining of the intestinal mucosa in the formation of the intestinal microbial-tissue complex as the leading links of metabolic disorders are discussed. The article presents data on the variability of short-chain fatty acids, bacterial genome in the development of obesity and type 2 diabetes.

The Role of Polyphenols in the Modulation of Plasma Non-Enzymatic Antioxidant Capacity (NEAC)

2012 ◽  
Vol 82 (3) ◽  
pp. 228-232 ◽  
Author(s):  
Mauro Serafini ◽  
Giuseppa Morabito
Keyword(s):  
Antioxidant Capacity ◽  
Dietary Intervention ◽  
Ex Vivo ◽  
The Body ◽  
Dietary Polyphenols ◽  
Enzymatic Antioxidant ◽  
Endogenous Antioxidant

Dietary polyphenols have been shown to scavenge free radicals, modulating cellular redox transcription factors in different in vitro and ex vivo models. Dietary intervention studies have shown that consumption of plant foods modulates plasma Non-Enzymatic Antioxidant Capacity (NEAC), a biomarker of the endogenous antioxidant network, in human subjects. However, the identification of the molecules responsible for this effect are yet to be obtained and evidences of an antioxidant in vivo action of polyphenols are conflicting. There is a clear discrepancy between polyphenols (PP) concentration in body fluids and the extent of increase of plasma NEAC. The low degree of absorption and the extensive metabolism of PP within the body have raised questions about their contribution to the endogenous antioxidant network. This work will discuss the role of polyphenols from galenic preparation, food extracts, and selected dietary sources as modulators of plasma NEAC in humans.

scholarly journals Role of Nutritive Factors in Infants Sleep Management

2021 ◽  
pp. 20-24
Author(s):  
Tatiana V. Turti ◽  
Irina A. Belyaeva ◽  
Elena P. Bombardirova ◽  
Pavel E. Sadchikov ◽  
Alexander Y. Nagonov
Keyword(s):  
Intestinal Microbiota ◽  
The Body ◽  
Individual Development ◽  
Factors Affecting ◽  
Sleep Management ◽  
Nocturnal Awakening ◽  
Sleep Schedule ◽  
Functional Components ◽  
Crucial Part

The organized infant’s sleep schedule is the crucial part of normal individual development. On the contrary, restless sleep, nocturnal awakening, long wakefulness can lead to deviations in physical, psychomotor, and cognitive development. Feeding schedule organized according to the time of a day and circadian rhythms (chrono-nutrition concept) can be useful for prevention and correction of such disorders. You are aware of the effect of such factors as feeding before night's sleep, nutrition at dark time of a day, diet enriched with triptophane and nucleotides, on the maturation and consolidation of infants sleep. The correlation between intestinal microbiota and factors affecting the circadian and metabolic activity of the body are presented: day-night cycles, sleep and wake, diet and nutrition. Targeted regulation of the intestinal microbiota through products enriched with functional components (prebiotics) can lead to the development of healthy sleep in infants via axis “brain – intestine – microbiota”.

scholarly journals A Triple Threat? The Role of Diet, Nutrition, and the Microbiota in T1D Pathogenesis

2021 ◽  
Vol 8 ◽  
Author(s):  
Emma E. Hamilton-Williams ◽  
Graciela L. Lorca ◽  
Jill M. Norris ◽  
Jessica L. Dunne
Keyword(s):  
Beta Cell ◽  
Intestinal Microbiota ◽  
Beta Cell Function ◽  
Cell Function ◽  
The Body ◽  
Islet Autoimmunity ◽  
Potential Mechanism ◽  
Modifiable Factors ◽  
And Function

In recent years the role of the intestinal microbiota in health and disease has come to the forefront of medical research. Alterations in the intestinal microbiota and several of its features have been linked to numerous diseases, including type 1 diabetes (T1D). To date, studies in animal models of T1D, as well as studies in human subjects, have linked several intestinal microbiota alterations with T1D pathogenesis. Features that are most often linked with T1D pathogenesis include decreased microbial diversity, the relative abundance of specific strains of individual microbes, and altered metabolite production. Alterations in these features as well as others have provided insight into T1D pathogenesis and shed light on the potential mechanism by which the microbiota plays a role in T1D pathogenesis, yet the underlying factors leading to these alterations remains unknown. One potential mechanism for alteration of the microbiota is through diet and nutrition. Previous studies have shown associations of diet with islet autoimmunity, but a direct contributing factor has yet to be identified. Diet, through introduction of antigens and alteration of the composition and function of the microbiota, may elicit the immune system to produce autoreactive responses that result in the destruction of the beta cells. Here, we review the evidence associating diet induced changes in the intestinal microbiota and their contribution to T1D pathogenesis. We further provide a roadmap for determining the effect of diet and other modifiable factors on the entire microbiota ecosystem, including its impact on both immune and beta cell function, as it relates to T1D. A greater understanding of the complex interactions between the intestinal microbiota and several interacting systems in the body (immune, intestinal integrity and function, metabolism, beta cell function, etc.) may provide scientifically rational approaches to prevent development of T1D and other childhood immune and allergic diseases and biomarkers to evaluate the efficacy of interventions.

scholarly journals ROLE OF DEEPANA PACHANA KARMA IN MANAGEMENT OF RASAPRADOSHAJA VIKARAS

2020 ◽  
pp. 33-38
Author(s):  
Ashrita S ◽  
Shivaprasad Hudeda
Keyword(s):  
Growth And Development ◽  
The Body ◽  
Physiological Functions ◽  
Root Cause ◽  
Proper Functioning ◽  
Two Factors ◽  
Metabolic Activities ◽  
Whole Tree

For a tree to stand erect with its branches, its roots must be strengthened by nourishing them timely such that the whole tree receives proper nourishment for its growth and development. Similarly, the Tridoshas, Saptha Dhatus and Tri-Malas are the roots strengthening this body when nourished timely. The Dosha-Dhatu-Mala in their state of normalcy enhances the strength of the body which is inferred through their respective physiological functions. This is achieved under the influence of two factors that is- Ahara and Agni. Ayurveda has endowed the function of thermogenesis and metabolism in the body to Agni. Proper functioning of Agni is responsible for all the metabolic activities in the body. Thereby, Agnimandya is said to be the root cause for all the diseases, as it results in the formation of Ama affecting the Rasavaha Srotas initially. The Ama Lakshanas resemble with the Rasapradoshaja Vikaras. Kapha Dosha is said to be the Asrayee in Rasa Dhatu and thereby the Rasa Vruddhi Lakshanas are similar to that of Kapha Vruddhi Lakshanas. So the Chikitsa as mentioned for Kapha Dosha can be implemented in Vruddhi/Kshaya of Rasa Dhatu. Shodhana without Ama-Pachana results in further complication. Therefore the line of treatment revolves around Srotoshodhana, Pachana, Agnideepana and Vatanulomana.

scholarly journals The gut microbiota of environmentally enriched mice regulates visual cortical plasticity

2021 ◽  
Author(s):  
Leonardo Lupori ◽  
Sara Cornuti ◽  
Raffaele M Mazziotti ◽  
Elisa Borghi ◽  
Emerenziana Ottaviano ◽  
...  
Keyword(s):  
Gut Microbiota ◽  
Cortical Plasticity ◽  
Brain Plasticity ◽  
Ocular Dominance ◽  
Standard Condition ◽  
Intestinal Bacteria ◽  
Short Chain Fatty Acids ◽  
The Body ◽  
Antibiotic Cocktail ◽  
Visual Cortical

Exposing animals to an enriched environment (EE) has dramatic effects on brain structure, function and plasticity. The poorly known "EE derived signals" mediating the EE effects are thought to be generated within the central nervous system. Here, we shift the focus to the body periphery, revealing that gut microbiota signals are crucial for EE-driven plasticity. Developmental analysis of intestinal bacteria composition in EE mice revealed striking differences from standard condition (ST) animals and enhanced levels of short-chain fatty acids (SCFA). Depleting the EE mice gut microbiota with an antibiotic cocktail decreased SCFA and prevented EE induction of adult ocular dominance (OD) plasticity, spine dynamics and microglia rearrangement. SCFA treatment in ST mice mimicked the EE induction of adult OD plasticity and morphological microglial rearrangement. Remarkably, transferring the microbiota of EE mice to ST recipients activated adult OD plasticity. Thus, taken together our data suggest that experience-dependent changes in gut microbiota regulate brain plasticity.

scholarly journals Metabolism Characteristics of Lactic Acid Bacteria and the Expanding Applications in Food Industry

2021 ◽  
Vol 9 ◽  
Author(s):  
Yaqi Wang ◽  
Jiangtao Wu ◽  
Mengxin Lv ◽  
Zhen Shao ◽  
Meluleki Hungwe ◽  
...  
Keyword(s):  
Lactic Acid ◽  
Lactic Acid Bacteria ◽  
Food Industry ◽  
Short Chain Fatty Acids ◽  
Fermented Food ◽  
The Body ◽  
Fermented Foods ◽  
Metabolic Characteristics ◽  
The One

Lactic acid bacteria are a kind of microorganisms that can ferment carbohydrates to produce lactic acid, and are currently widely used in the fermented food industry. In recent years, with the excellent role of lactic acid bacteria in the food industry and probiotic functions, their microbial metabolic characteristics have also attracted more attention. Lactic acid bacteria can decompose macromolecular substances in food, including degradation of indigestible polysaccharides and transformation of undesirable flavor substances. Meanwhile, they can also produce a variety of products including short-chain fatty acids, amines, bacteriocins, vitamins and exopolysaccharides during metabolism. Based on the above-mentioned metabolic characteristics, lactic acid bacteria have shown a variety of expanded applications in the food industry. On the one hand, they are used to improve the flavor of fermented foods, increase the nutrition of foods, reduce harmful substances, increase shelf life, and so on. On the other hand, they can be used as probiotics to promote health in the body. This article reviews and prospects the important metabolites in the expanded application of lactic acid bacteria from the perspective of bioengineering and biotechnology.

scholarly journals Role of gut metabolism of adrenal corticosteroids and hypertension: clues gut-cleansing antibiotics give us

2019 ◽  
Vol 51 (3) ◽  
pp. 83-89 ◽  
Author(s):  
David J. Morris ◽  
Andrew S. Brem
Keyword(s):  
Vascular Tissue ◽  
Biological Effects ◽  
Intestinal Bacteria ◽  
Short Chain Fatty Acids ◽  
Intestinal Microbiome ◽  
Systemic Hypertension ◽  
Hypertensive Animal ◽  
Metabolic Products

Intestinal bacteria can metabolize sterols, bile acids, steroid hormones, dietary proteins, fiber, foodstuffs, and short chain fatty acids. The metabolic products generated by some of these intestinal bacteria have been linked to a number of systemic diseases including obesity with Type 2 diabetes mellitus, some forms of inflammation, and more recently, systemic hypertension. In this review, we primarily focus on the potential role selected gut bacteria play in metabolizing the endogenous glucocorticoids corticosterone and cortisol. Those generated steroid metabolites, when reabsorbed in the intestine back into the circulation, produce biological effects most notably as inhibitors of 11β-hydroxysteroid dehydrogenase (11β-HSD) types 1 and 2. Inhibition of the dehydrogenase actions of 11β-HSD, particularly in kidney and vascular tissue, allows both corticosterone and cortisol the ability to bind to and activate mineralocorticoid receptors with attended changes in sodium handling and vascular resistance leading to increases in blood pressure. In several animal models of hypertension, administration of gut-cleansing antibiotics results in transient resolution of hypertension and transfer of intestinal contents from a hypertensive animal to a normotensive animal produces hypertension in the recipient. Moreover, fecal samples from hypertensive humans transplanted into germ-free mice resulted in hypertension in the recipient mice. Thus, it appears that the intestinal microbiome may not just be an innocent bystander but certain perturbations in the type and number of bacteria may directly or indirectly affect hypertension and other diseases.

scholarly journals Microbiome and Gluten

2015 ◽  
Vol 67 (Suppl. 2) ◽  
pp. 27-42 ◽  
Author(s):  
Yolanda Sanz
Keyword(s):  
Environmental Factors ◽  
Intestinal Microbiota ◽  
Disease Onset ◽  
Intestinal Bacteria ◽  
Epidemiological Studies ◽  
Experimental Models ◽  
Healthy Infants ◽  
Hla Dq ◽  
Environmental Trigger

Celiac disease (CD) is a frequent chronic inflammatory enteropathy caused by gluten in genetically predisposed individuals that carry disease susceptibility genes (HLA-DQ2/8). These genes are present in about 30-40% of the general population, but only a small percentage of carriers develops CD. Gluten is the key environmental trigger of CD, but its intake does not fully explain disease onset; indeed, an increased number of cases experience gluten intolerance in late adulthood after many years of gluten exposure. Consequently, additional environmental factors seem to be involved in CD. Epidemiological studies indicate that common perinatal and early postnatal factors influence both CD risk and intestinal microbiota structure. Prospective studies in healthy infants at risk of developing CD also reveal that the HLA-DQ genotype, in conjunction with other environmental factors, influences the microbiota composition. Furthermore, CD patients have imbalances in the intestinal microbiota (dysbiosis), which are not fully normalized despite their adherence to a gluten-free diet. Therefore, it is hypothesized that the disease can promote dysbiosis that aggravates CD pathogenesis, and dysbiosis, in turn, can initiate and sustain inflammation through the expansion of proinflammatory pathobionts and decline of anti-inflammatory mutualistic bacteria. Studies in experimental models are also contributing to understand the role of intestinal bacteria and its interactions with a predisposed genotype in promoting CD. Advances in this area could aid in the development of microbiome-informed intervention strategies that optimize the partnership between the gut microbiota and host immunity for improving CD management.

scholarly journals Role of the Intestinal Microbiome, Intestinal Barrier and Psychobiotics in Depression

Nutrients ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 927
Author(s):  
Paulina Trzeciak ◽  
Mariola Herbet
Keyword(s):  
Immune System ◽  
Intestinal Microbiota ◽  
Intestinal Barrier ◽  
Intestinal Bacteria ◽  
Intestinal Microbiome ◽  
Stress Reactions ◽  
Treatment Of Depression ◽  
Increased Activity ◽  
Excessive Activation

The intestinal microbiota plays an important role in the pathophysiology of depression. As determined, the microbiota influences the shaping and modulation of the functioning of the gut–brain axis. The intestinal microbiota has a significant impact on processes related to neurotransmitter synthesis, the myelination of neurons in the prefrontal cortex, and is also involved in the development of the amygdala and hippocampus. Intestinal bacteria are also a source of vitamins, the deficiency of which is believed to be related to the response to antidepressant therapy and may lead to exacerbation of depressive symptoms. Additionally, it is known that, in periods of excessive activation of stress reactions, the immune system also plays an important role, negatively affecting the tightness of the intestinal barrier and intestinal microflora. In this review, we have summarized the role of the gut microbiota, its metabolites, and diet in susceptibility to depression. We also describe abnormalities in the functioning of the intestinal barrier caused by increased activity of the immune system in response to stressors. Moreover, the presented study discusses the role of psychobiotics in the prevention and treatment of depression through their influence on the intestinal barrier, immune processes, and functioning of the nervous system.

Sign in / Sign up

Export Citation Format

Share Document